metoclopramide has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted a cross-sectional study using the Korea Adverse Event Reporting System database between July 1, 2010, and June 30, 2015." | 1.51 | Current Status of Parkinsonism-Related Adverse Events and Associated Drugs in Korea. ( Kim, S; Suh, HS, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, S | 1 |
| Suh, HS | 1 |
1 other study available for metoclopramide and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Current Status of Parkinsonism-Related Adverse Events and Associated Drugs in Korea.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antiemetics; An | 2019 |